2016
DOI: 10.1186/s13073-016-0363-3
|View full text |Cite
|
Sign up to set email alerts
|

Application of RNAi-induced gene expression profiles for prognostic prediction in breast cancer

Abstract: Homologous recombination (HR) is the primary pathway for repairing double-strand DNA breaks implicating in the development of cancer. RNAi-based knockdowns of BRCA1 and RAD51 in this pathway have been performed to investigate the resulting transcriptomic profiles. Here we propose a computational framework to utilize these profiles to calculate a score, named RNA-Interference derived Proliferation Score (RIPS), which reflects cell proliferation ability in individual breast tumors. RIPS is predictive of breast c… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2017
2017
2019
2019

Publication Types

Select...
2
1

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(4 citation statements)
references
References 55 publications
0
4
0
Order By: Relevance
“…A similar statistical framework has been applied to integrate cancer gene expression data with gene knockdown profiles with detailed description available from Wang et al . 30 . The calculated BRCA scores were highly consistent with each other using BRCA1 -, BRCA 2- and BRCA1 / 2 -based BRCAness profiles in all datasets we applied in our analyses (Supplementary Fig.…”
Section: Methodsmentioning
confidence: 99%
See 2 more Smart Citations
“…A similar statistical framework has been applied to integrate cancer gene expression data with gene knockdown profiles with detailed description available from Wang et al . 30 . The calculated BRCA scores were highly consistent with each other using BRCA1 -, BRCA 2- and BRCA1 / 2 -based BRCAness profiles in all datasets we applied in our analyses (Supplementary Fig.…”
Section: Methodsmentioning
confidence: 99%
“…The Mann-Whitney-Wilcoxon Test was applied to calculate the difference. The calculations of CVN burden and mutation burden were same with our previously study 30 .…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…A common scenario that demonstrates the need for robust authentication and authorization to cloud-based genomics data is joint analysis of public and private datasets. For instance, an active area of research in precision oncology is using omics data to statistically learn biomarker signatures to guide selection of therapies [11], [12], [13], [14] most likely to be effective for a particular tumor. In these studies, both private as well as public datasets such as The Cancer Genome Atlas (TCGA) require authorized access.…”
Section: A Motivating Applicationmentioning
confidence: 99%